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Abstract: Background: Bumped kinase inhibitors (BKIs) are potential drugs for neosporosis treatment
in farm animals. BKI-1294 exposure results in the formation of multinucleated complexes (MNCs),
which remain viable in vitro under constant drug pressure. We investigated the formation of BKI-1294
induced MNCs, the re-emergence of viable tachyzoites following drug removal, and the localization
of CDPK1, the molecular target of BKIs. Methods: N. caninum tachyzoites and MNCs were studied by
TEM and immunofluorescence using antibodies directed against CDPK1, and against NcSAG1 and
IMC1 as markers for tachyzoites and newly formed zoites, respectively. Results: After six days of drug
exposure, MNCs lacked SAG1 surface expression but remained intracellular, and formed numerous
zoites incapable of disjoining from each other. Following drug removal, proliferation continued, and
zoites lacking NcSAG1 emerged from the periphery of these complexes, forming infective tachyzoites
after 10 days. In intracellular tachyzoites, CDPK1 was evenly distributed but shifted towards the
apical part once parasites were extracellular. This shift was not affected by BKI-1294. Conclusions:
CDPK1 has a dynamic distribution depending on whether parasites are located within a host cell or
outside. During MNC-to-tachyzoite reconversion newly formed tachyzoites are generated directly
from MNCs through zoites of unknown surface antigen composition. Further in vivo studies are
needed to determine if MNCs could lead to a persistent reservoir of infection after BKI treatment.
Keywords: bumped kinase inhibitor; calcium-dependent protein kinase; immunofluorescence;
immunogold labeling; inner membrane complex; neosporosis; surface antigen; tachyzoite;
transmission electron microscopy
1. Introduction
The phylum Apicomplexa includes important pathogens of animals and/or man such as
Plasmodium falciparum, Cryptosporidium parvum, Eimeria spp., Babesi spp, Theileria spp., Toxoplasma gondii,
and Neospora caninum among others. N. caninum is closely related to T. gondii, can infect many different
Pathogens 2020, 9, 382; doi:10.3390/pathogens9050382 www.mdpi.com/journal/pathogens
Pathogens 2020, 9, 382 2 of 19
intermediate hosts and is able to proliferate in a wide range of tissues and in many different cell types
in vitro. However, in contrast to T. gondii, N. caninum is an important causative agent of abortion or birth
of weak offspring in cattle, and to a lesser extent, in sheep and other ruminants [1]. The sexual cycle of
N. caninum occurs in dogs, which do not only shed oocysts that become infective after sporulation but
can also act as intermediate host and, are affected by neurological clinical signs. No vaccine is currently
licensed for the prevention of bovine or canine neosporosis and so far, immuno- or chemotherapeutical
treatments do not exist [2,3].
Protein kinases are involved in a plethora of different functional activities that control essential
aspects of apicomplexan biology, including host cell invasion, intracellular proliferation and egress [4,5].
Calcium-dependent protein kinases (CDPKs) are not found in mammals, and therefore constitute
interesting targets for anti-apicomplexan drugs. In particular, CDPK1 is intensively studied in
target-based drug development against a wide range of apicomplexans including P. falciparum, T. gondii,
N. caninum, Sarcocystis neurona, Besnoitia besnoiti, B. bovis, T. equi and C. parvum [6].
Based on co-crystal structure investigations of T. gondii CDPK1, a class of ATP-competitive
inhibitors named bumped kinase inhibitors (BKIs) has been developed [7]. They exhibit a high degree
of efficacy and specificity for apicomplexan CDPK1 relative to mammalian kinases, and they block the
invasion of T. gondii tachyzoites into host cells [8] and egress [9] from host cells. These BKIs fit into the
ATP binding cavity not only of T. gondii CDPK1 but also of CDPK1 isoforms of other apicomplexans
including N. caninum [10].
Consequently, several BKIs have been studied so far with respect to efficacy against N. caninum
infection, in particular the pyrazolopyrimidine BKI-1294. BKI-1294 interferes with host cell invasion
and egress but is not parasiticidal [10]. BKI-1294 is highly active in pregnant mouse models for
neosporosis [11] and for toxoplasmosis [12], and in a pregnant sheep model for toxoplasmosis [13]. Other
BKIs are also effective against neosporosis, as shown in pregnant mouse [14] and sheep [15] models.
It is unclear, so far, how BKI-1294 (and related compounds) affect the intracellular stages of
apicomplexans. We have demonstrated in previous studies that prolonged exposure of infected cells to
this compound results in the formation of multinucleated complexes (MNCs) [10]. We have reproduced
and confirmed this observation with other N. caninum strains (Nc-1, Nc-Liv, and Nc-Spain7), and with
the T. gondii strains RH and ME49. It was further observed that BKI-1294 induced MNCs exhibit a
deregulated gene expression pattern as evidenced by the simultaneous expression of bradyzoite and
tachyzoite antigens [11]. These results suggest that MNCs could constitute a drug-induced resting
stage assuring the survival of the parasite until the release of the drug pressure.
To get an insight into the cell biology of MNCs, we have investigated their ultrastructure,
the spatiotemporal pattern of established marker proteins for N. caninum development, and the pattern
of NcCDPK1, the BKI target, in MNCs in comparison to intra- and extracellular tachyzoites. Moreover,
we show how newly formed tachyzoites are generated once the drug is removed and try to answer the
question of whether tachyzoite reconversion is achieved by only a few drug-resistant/drug-adapted
parasites, or whether newly formed tachyzoites are generated directly from MNCs.
2. Results
2.1. Ultrastructural Characteristics of Multinucleated Complexes (MNCs)
Transmission electron microscopy (TEM) micrographs of N. caninum tachyzoites grown in human
foreskin fibroblasts (HFF) monolayers for two days in the absence of BKI-1294 are shown in Figure 1A,
and a higher magnification view is shown in Figure 1B. After two days of culture, intracellularly
proliferating tachyzoites were located within a parasitophorous vacuole (PV), which is surrounded
by a parasitophorous vacuole membrane (PVM) (Figure 1A). The PV is in close proximity to the host
cell nucleus, and often associated with host cell mitochondria (Figure 1B). Dense granules, rhoptries,
and micronemes are hallmarks of apicomplexan parasites and could be easily identified. Tachyzoites
were embedded in the PV-matrix, which consists of a network of membranous tubules. Individual
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tachyzoites were always surrounded by a thick plasma membrane that contains three layers, namely
an inner membrane complex (IMC), and a double-layered plasmalemma at the outer surface.
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After two days of culture in the presence of 5 µM BKI-1294, small MNCs containing 3–5 nuclei 
were found. An example is shown in Figure 2A and at lower magnification in Figure 2B. MNCs were 
also located within a PV, and exhibited similar features as the individual tachyzoites, including an 
intact conoid, and secretory organelles (dense granules, rhoptries, and micronemes). Higher 
magnification shows that MNCs were surrounded by the typical three-layered plasma membrane 
seen in tachyzoites. However, individual zoites were formed and are separated from each other by 
only one membrane layer, which appears to branch off from the outer membrane (see Figure 2A, 
large horizontal red arrow), and continues along the surface of the newly formed zoites (small arrows 
in Figure 2A). In addition, the presence of an intact mitochondrion indicates that these MNCs were 
viable and metabolically active. The matrix of the PV contained similar membranous tubules as in 
untreated cultures, but also more granular components were present. 
Figure 1. f proliferating non-drug-tr ated N. caninum tachyzoites. The boxed area in
(A) is enlarged in (B); pv = parasitophorous vacuole; pvm = parasitophorous vacuole membrane;
pm = parasitophorous vacuole matrix; dg = dense granules; rop = rhoptries; mic = micronemes;
mito = mitochondrion; hcmito = host cell mitochondrion; * indicate the triple-layered outer membrane
of individual tachyzoites. Bars in (A) = 0.9 µm, in (B) = 0.2 µm.
After two days of culture in the presence of 5 µ B I-1294, small MNCs containing 3–5 nuclei
were found. An example is shown in Figure 2A and at lower magnification in Figure 2B. MNCs were
also located within a PV, and exhibited similar features as the individual tachyzoites, including an intact
conoid, and secretory organelles (dense granules, rhoptries, and micronemes). Higher magnification
shows that MNCs were surrounded by the typical three-layered plasma membrane seen in tachyzoites.
However, individual zoites were formed and are separated from each other by only one membrane
layer, which appears to branch off from the outer membrane (see Figure 2A, large horizontal red arrow),
and continues along the surface of the newly formed zoites (small arrows in Figure 2A). In addition,
the presence of an intact mitochondrion indicates that these MNCs were viable and metabolically
active. The matrix of the PV contained similar membranous tubules as in untreated cultures, but also
more granular components were present.
On day four of BKI-1294 treatment (Figure 2C,D), MNCs had increased in size, as had the number
of individual nuclei. Newly formed zoites with intact organelles were still visible and surrounded by a
single membrane layer (red arrows in Figure 2D). On day nine of BKI-1294 treatment (Figure 3A–C),
MNCs exhibited a further increase in size, zoites were densely packed, separated by a single membrane,
and a larger number of newly formed conoids were evident. These MNCs were still surrounded
by a triple-layered plasma membrane, and the matrix of the PV appeared more granular, while the
tubulo-vesicular membranous network had largely disappeared (Figure 3C,D).
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Figure 3. TEM of MNCs after nine days of continuous BKI-1294 treatment. The boxed areas in (B) and
(C) are enlarged in (C), and (D), respectively; pv = parasitophorous vacuole; pm = parasitophorous
vacuole matrix; nuc = nucleus; mito = mitochondrion; con = conoid; small red arrows point toward the
IMC that separates individual zoites; * indicate the triple-layered outer membrane of the MNC. Bars in
(A) and (B) = 2.8 µm, (C) = 0.8 µm, (D) = 0.6 µm.
2.2. Expression of NcSAG1 and NcIMC1 during the Formation of MNCs and Subsequent Drug Release
Antibodies against the inner membrane complex protein 1 (IMC1) serve as markers for the IMC
that surrounds newly formed zoites, while antibodies directed against the major surface antigen
1 (NcSAG1) bind exclusively to the outer layer of the tachyzoite plasma membrane. As expected,
non-treated control cultures showed tachyzoites undergoing extensive proliferation, forming vacuoles
containing numerous parasites that exhibited both anti-IMC1 and anti-NcSAG1 antibody labeling
closely associated with their surface (Figure 4A,C,E). After four days of culture without drug treatment,
host cell lysis started to occur (not shown). In cultures treated with BKI-1294 for one, two and, four
days (Figure 4B,D,F), staining for IMC1 differed from NcSAG1 labeling. NcSAG1 was localized largely
on the surface or peripheral regions of the MNCs, while the interior was only diffusely labeled. In
addition, granular deposits were frequently seen within the host cell cytoplasm from day two of
treatment onwards. In contrast, IMC1 staining was found to be associated with the plasma membrane
of individual newly formed zoites in the interior of the MNCs. On day six of BKI-1294 treatment
(Figure 4G), NcSAG1 labeling at the periphery of MNCs was diminished, and the corresponding
staining within the complex appeared indistinct, while anti-IMC1 labeling revealed the presence of
numerous newly formed zoites that were mostly devoid of anti-NcSAG1 labeling.
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Figure 4. IF staining of non-treated proliferating N. caninum tachyzoites (A,C,E), and drug-treated
parasites (B,D,F,G) after two, four and six days of culture in the absence (–) or presence (+) of BKI-1294.
Anti-IMC1 staining is green, NcSAG1 is labeled in red, nuclei are stained with DAPI (blue). Small
arrows point towards SAG1-deposits within the host cell cytoplasm.
In the next step, we investigated the re-differentiation of MNCs to tachyzoites after the removal of
BKI-1294. NcSAG1 was found on the surface of MNCs until day two post-drug removal (pdr) (Figure 5A,B).
However, NcSAG1 labeling became less defined with time, and was also present as a diffuse staining
located in the neighboring area of the MNCs, most likely in the host cell cytoplasm (Figure 5A,B). In
contrast, staining with anti-NcIMC1 antibody marking the presence of newly formed zoites increased
in the periphery (Figure 5B, green arrows). Specimens viewed on day seven lacked defined NcSAG1
surface staining, and NcSAG1 became more prominent in the MNC interior (Figure 5C). On day seven,
the numbers of newly formed zoites increased with time, as did the number of zoites present at the
periphery by becoming more frequent, and this was more prominently seen on day 10 pdr (Figure 5D, left
panel). However, also from day 10 pdr onwards, newly formed and obviously proliferating tachyzoites
could be detected within new PVs, indicating that these zoites had emerged from their MNCs, infected
neighboring cells, and had converted into tachyzoites (Figure 5D, right panel).
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NcCDPK1 is the primary molecular target of BKI-1294 [10]. To investigate the distribution of 
NcCDPK1 during MNC formation, we employed an antibody directed against the homologous T. 
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Figure 5. IF staining of MNCs after four days of BKI-1294 treatment followed by 10 days of culture
without the drug. Specimens were fixed and processed at day zero and day two (A), day two and four
(B), day seven (C), and day 10 post drug removal (pdr) (D). Anti-IMC1 staining is green, NcSAG1 is
labeled in red, nuclei are stained with DAPI (blue). Small white arrows point toward SAG1-deposits
within the host cell cytoplasm. Small green arrows indicate peripheral newly formed zoites stained
with anti-IMC1, but not with anti-NcSAG1.
2.3. Expression of NcCDPK1 during the Formation of MNCs, Tachyzoite Egress, and Extracellular
Maintenance of Tachyzoites
NcCDPK1 is the primary molecular target of BKI-1294 [10]. To investigate the distribution of
NcCDPK1 during MNC formation, we employed an antibody directed against the homologous T. gondii
CDPK1. This antibody had been previously shown to cross-react with Sarcocystis neurona CDPK1 [16].
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On Western blots of N. caninum tachyzoite extracts (Figure 6A), it reacted with a 57 kDa band, which
corresponded to the predicted molecular weight of NcCDPK1 [10]. This band was detected in the
Triton-X-100 soluble fraction only. IF labeling of intracellular N. caninum tachyzoites grown in HFF
resulted in evenly distributed cytoplasmic staining of parasites, but not within the parasite nuclei
(Figure 6B). On day three of treatment, NcCDPK1 staining of the MNC interior was ill-defined, and
not confined to individual newly formed zoites, but rather evenly distributed within the interior of
the complexes (Figure 6D). On day six of treatment, the intensity of NcCDPK1 staining was reduced
(Figure 6E).
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TgCDPK1 (CDPK1), the corresponding rabbit pre-immune serum (pre-immune), anti-alpha-tubulin 
clone B-5–1-2 (Tub), or monoclonal anti-NcSAG1 antibody (SAG1). NcCDPK1-NcSAG1-double IF 
labeling of N. caninum tachyzoites cultured for three days in HFF is shown in (B), and (C) is the 
corresponding pre-immune serum. MNCs after three and six days of BKI-1294 treatment are shown 
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2.4. Expression of NcCDPK1 during the Formation of BKI-1294 Induced MNCs, Egress, and Extracellular 
Maintenance 
Figure 6. Western blots of N. caninum tachyzoite extracts and IF staining of MNCs. (A) shows N. caninum
tachyzoites extracted in Triton-X-100, and soluble (SN) and insoluble (P) proteins were separated
by SDS-PAGE and blotted onto a nitrocellulose membrane. Blots were stained with anti-TgCDPK1
(CDPK1), the corresponding rabbit pre-immune serum (pre-immune), anti-alpha-tubulin clone B-5–1-2
(Tub), or monoclonal anti-NcSAG1 antibody (SAG1). NcCDPK1-NcSAG1-double IF labeling of
N. caninum tachyzoites cultured for three days in HFF is shown in (B), and (C) is the corresponding
pre-immune serum. MNCs after three and six days of BKI-1294 treatment are shown in (D) and
(E), respectively. Anti-CDPK1 staining is green, NcSAG1 is labeled in red, nuclei are stained with
DAPI (blue).
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2.4. Expression of NcCDPK1 during the Formation of BKI-1294 Induced MNCs, Egress, and Extracellular
Maintenance
In tachyzoites purified at 4 ◦C, NcCDPK1 staining was uniformly distributed within the parasite
cytoplasm (Figure 7A), similar to what was previously found in intracellular tachyzoites in situ
(Figure 7B). When tachyzoites were purified at 21 ◦C, NcCDPK1 was located to the apical region of
the tachyzoites (Figure 7B). This apical location of NcCDPK1 was also found in parasites that were
exposed to 5 µM BKI-1294 for 15 min prior to separation from host cells in the presence of BKI-1294
(Figure 7C). To confirm this, infected cells were pre-fixed in paraformaldehyde for 10 min and were
then subjected to host cell lysis and parasite isolation. In these cells, NcCDPK1 was distributed evenly
in the cytoplasm, as seen in intracellular parasites (Figure 7D).
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Figure 7. IF labeling of extracellular N. caninum tachyzoites. Parasites were separated from host cells
either at 4 ◦C (A), at 21 ◦C (B), or at 21 ◦C in the presence of BKI-1294 (C). Panel (D) shows tachyzoites
that were pre-fixed intracellularly with paraformaldehyde, then separated from host cells and labeled.
NcCDPK1 is labeled in green, NcSAG1 is red, and DAPI in blue.
When tachyzoite egress was induced by dithiothreitol (DTT), a well-established trigger of
egress of tachyzoites from host cells [17], a similar apical shift in NcCDPK1 localization was observed
(Figure 8A). Double IF labeling of extracellular tachyzoites with anti-CDPK1 and anti-tubulin (Figure 8B)
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or anti-NcMIC2 antibodies (Figure 8C) showed that the polarized NcCDPK1 staining was localized
at the apical part of N. caninum tachyzoites. In comparative Western blots of secreted fractions
versus intracellular fractions, only small amounts of NcCDPK1 were found to be translocated to the
extracellular medium, indicating that only a small portion of this protein was actually secreted or
released by these parasites (Figure 8D).
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exclusive and pronounced apical location of NcCDPK1, with gold particles at the very tip, sometimes 
appearing even on the apical surface of tachyzoites, and frequently associated with micronemes. No 
gold particles could be detected at the posterior end of extracellular parasites. 
Figure 8. IF labeling of extracellular N. caninum tachyzoites and Western blots of secreted versus
non-secreted fractions. (A) shows tachyzoites after DTT-induced egress labeled with anti-CDPK1
and anti-NcSAG1 antibodies. In (B) and (C) CDPK1-labeled parasites were double-labeled
with anti-alpha-tubulin clone B-5–1-2 (Tubulin), or monoclonal anti-NcMIC2 antibody (NcMIC2).
Anti-CDPK1 staining is green, NcSAG1, Tubulin, and NcMIC2 are labeled in red, nuclei are stained with
DAPI (blue). (D) Comparative Western blot of secreted extracellular fractions (EC) versus intracellular
fractions (IC) stained with anti-CDPK1 antibodies (CDPK1) and monoclonal antibody directed against
NcSAG1 (SAG1).
Immunogold-TEM of intracellular and extracellular tachyzoites was carried out in order to
determine which tachyzoite compartments and/or organelles would be labeled with anti-CDPK1
antibodies. Intracellularly proliferating tachyzoites (Figure 9) exhibited a marked staining of the
anterior end, mostly situated around the sub-membranous apical part of the parasites, just below the
plasma membrane. Few gold particles were associated with micronemes. In addition, no or only a little
immunogold-labeling could be found within the nucleus or secretory organelles such as rhoptries and
dense granules (Figure 9A,D,F). The frequency of gold particles at the posterior region of intracellular
tachyzoites was less pronounced but immunogold labeling was found in the cytoplasm near the nuclear
periphery and underneath the posterior plasma membrane (Figure 9B,C,E). In contrast, immunogold
TEM of extracellular tachyzoites (Figure 10) confirmed the almost exclusive and pronounced apical
location of NcCDPK1, with gold particles at the very tip, sometimes appearing even on the apical
surface of tachyzoites, and frequently associated with micronemes. No gold particles could be detected
at the posterior end of extracellular parasites.
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Figure 9. Immunogold-TEM on section labeling of intracellular N. caninum tachyzoites with anti-CDPK1
antibodies and secondary 10 nm gold anti-rabbit conjugates. (A), (D) and (F) show the apical portion of
a tachyzoite. (B), (C) and (E) show the posterior parts, and the small inserts indicate the corresponding
low magnification views. AP = apical part; pv = parasitophorous vacuole; rop = rhoptries; dg = dense
granules; mic = micronemes; nuc = nucleus. Small arrows point toward gold particles indicating the
presence of NcCDPK1. Bar in (A) and (B) = 0.15 µm; (C) and (D) = 0.25 µm; (E) and (F) = 0.2 µm.
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Figure 10. Immunogold-TEM on section labeling of extracellular N. caninum tachyzoites with
anti-CDPK1 antibodies and secondary 10 nm gold anti-rabbit conjugates. The tachyzoite depicted in
(A) is shown at higher magnification in (B), and the one in (D) at lower magnification in (E). rop =
rhoptries; dg = dense granules; mic = micronemes; nuc = nucleus. Small arrows point toward gold
particles indicating the presence of NcCDPK1. Bar in (A) = 0.8 µm; in (B) = 0.15 µm; in (C) = 0.3 µm; in
(D) = 0.15 µm; in (E) = 0.5 µm.
3. Discussion
Previous in vitro studies have shown that BKI-1294 treatment inhibited host cell invasion but
did not act parasiticidal. As a response to the treatment, intracellular tachyzoites differentiated into
MNCs [10,11]. Despite this interference, MNCs remained viable and metabolically active for extended
periods of time. Even after continuous treatments with 5 µm BKI-1294 for 20 days, MNCs had
re-differentiated into tachyzoites that then resumed proliferation [11].
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The ultrastructure of MNCs was investigated by TEM, which demonstrated that the entire MNC
surface was formed by a triple-layered plasma membrane, as in tachyzoites. The membrane separating
the individual zoites was much thinner compared to the outer plasma membrane surrounding the
MNCs. In addition, TEM at higher magnification showed that the inner membrane was branching
off from the triple-layered plasmalemma and surrounding the entire newly formed zoites, which
themselves were not able to disconnect from the complex and remained trapped inside the host
cell. Thus, BKI-1294 interferes with the completion of the lytic cycle by inhibiting the disjunction of
individual zoites from each other. This leads to the formation of MNCs that form a schizont-like,
multinucleated and intracellular organism, which contains numerous apical complexes with conoid,
rhoptries, micronemes, dense granules, and mitochondria.
Which developmental steps occur during MNC differentiation and de-differentiation? During
the first four days of continuous drug treatment, NcSAG1, the major surface antigen-specific for
tachyzoites [18,19], is clearly visible on the plasma membrane surrounding the MNCs. However, from
day six onwards, NcSAG1 moves from the outer membrane into the interior of the complex. We could
not ascertain whether NcSAG1 became associated with specific structural entities within the MNC.
Although NcSAG1 was not present on the MNC surface anymore, the triple-layered plasma membrane
was still present and intact after nine days of drug treatment as shown by TEM (see also [10]). Thus, it
is conceivable that (an)other member(s) of the surface antigen glycoprotein-related sequences (SRS)
superfamily could potentially be expressed on the surface of these complexes ([20]).
How do MNCs re-differentiate into infective tachyzoites? Following the release of drug pressure
after four days of treatment, re-differentiation into novel infective tachyzoites takes up to 10 additional
days. In the first phase of two to four days, NcSAG1 surface labeling of these MNCs adopted a less
clearly delineated appearance. Some NcSAG1 deposits were shed from the surface and were detected
as a diffuse staining outside of the MNC but adjacent to the MNC. Staining with anti-IMC1 antibody,
reminiscent for newly formed zoites, appeared closer to the MNC surface from day two pdr onwards.
During subsequent timepoints, NcSAG1 staining largely disappeared from the surface but became more
prominent in the MNC interior. However, we could not determine whether this interior staining was
associated with any distinct structural entities within the MNC. In addition, IMC1-positive parasites
were frequently detected to be associated with the MNC surface already on day four pdr. From days
7–10 onwards, the number of newly formed zoites stained by anti-IMC1 antibody increased markedly,
and such zoites were increasingly found in the periphery of the MNCs, seemingly heading outwards.
Newly formed PVs containing obviously proliferating tachyzoites could be detected from day 10 pdr
onwards. This indicates that the block of disjunction was finally alleviated. Zoites had emerged from
their MNCs, and infected neighboring cells and converted into NcSAG1-positive tachyzoites. We
could not determine whether these emerging zoites already expressed NcSAG1, or an alternative SRS
protein. However, we did not detect emerging zoites that were clearly stained with both antibodies
during this final stage of re-differentiation.
The steps during MNC formation and re-differentiation into tachyzoites after drug removal are
schematically depicted in Figure 11. The classical steps of the lytic cycle, including initiation, elongation
and emergence of daughter zoites appear to occur continuously in these MNCs, but the daughter
zoites fail to undergo disjunction. Consequently, a schizont-like stage appears, which exhibits an outer
NcSAG1-containing plasma membrane and is able to survive for prolonged periods of time. Upon
removal of the drug, NcSAG1 gradually disappeared from the MNC surface. The temporal block
in completing cytokinesis was alleviated, which eventually leads to the emergence and subsequent
continuous proliferation of tachyzoites, that either do, or do not, express NcSAG1.
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Figure 11. Schematic representation of the steps of the lytic cycle of N. caninum on the right-hand side,
and the events occurring during BKI-1294 treatment and subsequent removal of the compound on the
left. The different steps of the lytic cycle have been previously described by Ouologuem and Roos [21].
NcCDPK1, the molecular target of BKI-1294 and related compounds, exhibits a dispersed and
homogenous cytoplasmic, extranuclear localization in intracellular tachyzoites, as shown by IF and
immunogold-on-section labeling. The same pattern occurred in MNCs formed after three days of
BKI-1294 treatment, and subsequently, NcCDPK1 staining intensity was greatly reduced. These
findings are not in agreement with previous studies with GFP- and HA-tagged TgCDPK1 localized
in the cytoplas as well as in the nucleus of T. gondii tachyzoites [7]. The different results could be
explained by the overexpression of tagged proteins. Moreover, we have evidence that, under these
experimental conditions, the apical shift seen in N. caninum tachyzoites did not occur in T. gondii
tachyzoites of the RH and ME49 strains, and also not in the closely related B. besnoiti (data not shown).
A relocation of NcCDPK1 is only seen in tachyzoites that are isolated at elevated temperatures (21
◦C). Since DTT treatment has the same effect, it is conceivable that a sudden increase of intracellular
calcium triggers this relocation [22]. The relocated NcCDPK1 is localized in the sub-membranous
compartment of the apical complex, near the conoid, and within some, but not all, micronemes, as
well as on the tachyzoite surface, but not in rhoptries nor dense granules. The localization in the
icronemes implies that NcCDPK1 could be a part of the secreted fraction of N. caninum tachyzoites.
However, secretion assays showed that only small amounts of the total cellular NcCDPK1 are found in
the extracellular medium. Therefore, NcCDPK1 cannot be considered as a major component of the
secreted fraction. Previous studies have shown that another CDPK, TgCDPK3, is also localized to
the inner side of the plasma membrane. TgCDPK3 is the orthologue of Plasmodium spp. CDPK1, and
regulates Ca2+ ionophore- and DTT-induced host cell egress, but neither motility nor invasion [23].
In the chicken parasite Eimeria tenella, CDPK3, involved in host cell invasion, exhibits a dispersed
localization during the first schizogony and intense specific staining at the apical end of the sporozoites
after early infection of host cells [24].
In conclusion, our results suggest that MNCs formed as a response to treatment with BKI-1294
constitute an intracellular stage that enables survival and limited proliferation under adverse conditions,
similar to the tissue cyst encapsulated bradyzoite stage. Previous findings showed BKI-1294 treatment
triggered the increased expression of both, SAG1 and BAG1 transcript and protein expression [11]
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(MNC formation is also observed with T. gondii [11], B. besnoiti [25], and S. neurona [16], and this
not only upon treatment with BKI-1294, but also upon treatment with other BKIs. MNC formation
may also occur as a response to other, non-parasiticidal drugs and could, therefore, constitute an
important strategy in drug adaptation or resistance. Therefore, it may be worthwhile to screen for drug
combinations that do not lead to MNC formation, and regrowth in culture, to avoid the possibility of
residual infection in vivo. However, it is equally possible that the MNCs are more susceptible to host
innate and acquired immunity, and may be eliminated during drug treatment. In vivo experiments are
required to determine if MNC formation becomes a persistence issue after drug therapy.
4. Materials and Methods
4.1. Tissue Culture Media, Biochemicals, and Drugs
If not stated otherwise, all tissue culture media were purchased from Gibco-BRL (Zürich,
Switzerland), and biochemicals were from Sigma (St. Louis, MO, USA). Bumped kinase inhibitor-1294
was provided by the Center for Emerging and Reemerging Infectious Diseases (CERID), Division of
Allergy and Infectious Diseases, Department of Medicine, University of Washington (Seattle, WA,
USA), and was stored at room temperature. For in vitro studies, 20 mm stock solutions were prepared
in dimethyl sulfoxide (DMSO) and they were stored at −20 ◦C.
4.2. Host Cell Cultivation and Parasite Maintenance
Human foreskin fibroblasts (HFF; ATCC® SCRC-1041™) and BALB/c dermal fibroblasts (ATCC®
CCL-163) were maintained in Dulbecco’s modified Eagle medium (DMEM), and the monkey kidney
cell line Marc-145 (ATCC® CRL-12231) was cultured in DMEM without sodium pyruvate and HEPES.
Media contained phenol red and were supplemented with 10% heat-inactivated and sterile filtered
fetal calf serum (FCS), 100 U of penicillin/mL, and 100 µg streptomycin/mL. The N. caninum-Spain7
(Nc-Spain7) isolate was maintained by infecting semi-confluent HFF or Marc-145 monolayers and
cultivation at 37 ◦C and 5% CO2, with passages once or twice per week. Tachyzoites were separated
from host cells by scraping the cell material from culture flasks when they were still largely intracellular
(>90% of undisrupted PVs), and infected cells were repeatedly passed through a 25-gauge needle at
4 ◦C [26]. In some experiments, parasite-host cell separation was performed at 21 ◦C, either in the
presence or absence of 5 µm BKI-1294.
4.3. Analysis of N. caninum Tachyzoite Triton-X-100 and Secreted Fractions by Western Blots
Purified N. caninum tachyzoites were subjected to Triton X-100 extraction as previously
described [27], and excretory/secretory fractions were prepared according to a previously published
method [28]. Fractions corresponding to the same number of tachyzoites, were separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblots were prepared by
transfer onto nitrocellulose. Non-specific binding sites were blocked in 3% bovine serum albumin
(BSA) in TBS-Tween (20 mm Tris–HCl, 150 mm NaCl, 0.3% Tween 20) for 2 h at room temperature.
Blots were labeled with rabbit anti-TgCDPK1 antiserum diluted 1:5000, mouse monoclonal anti-tubulin
(clone 5–2-2; Sigma) at 1:2000, and mouse monoclonal anti-NcSAG1 (1:5000; [11]), all diluted in
TBS-Tween/0.3% BSA overnight at 4 ◦C. Bound antibodies were visualized using goat anti-rabbit-alkaline
phosphatase conjugates (Promega) according to the instructions provided by the manufacturer.
4.4. Immunofluorescence (IF) Labeling of Intracellular Tachyzoites
For staining of intracellular parasites, freshly split HFF were seeded onto glass coverslips placed
into 24-well tissue culture plates at 2× 104 tachyzoites/well in 1 mL DMEM cell culture medium/well [11].
After three days, a semi-confluent monolayer had formed, which was then infected with 2 × 105
freshly purified Nc-Spain7 tachyzoites at 37 ◦C/5% CO2. At 4 h post-infection (p.i.), the medium and
non-adherent parasites were aspirated and replaced by fresh culture medium, either supplemented
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with BKI-1294 leading to MNC formation, or the corresponding amount of DMSO, and samples were
maintained at 37 ◦C/5% CO2 for different time periods as indicated in the text. In some experiments,
drug pressure was removed after four days and parasite cultures were allowed to recover during
extended periods of time thereafter. For fixation, coverslips were rinsed twice in PBS, and were then
placed into 3% paraformaldehyde in PBS for 10 min at RT, followed by immersion in a 1:1 mixture of
methanol/acetone for 20 min at −20 ◦C [29]. Subsequently, the samples were rehydrated in PBS at RT
for 3 min, and were stored overnight at 4 ◦C in PBS/3% BSA to block unspecific binding sites. They
were then incubated for 25 min with the primary antibodies diluted in PBS/0.3% BSA. The polyclonal
anti-TgCDPK1 antibody was used at a dilution of 1:500, the mouse monoclonal antibody directed
against NcSAG1 at 1:2000 [11], rabbit anti-IMC1 antiserum (kindly provided by Prof. Dominique
Soldati, University of Geneva) was applied at 1:500, monoclonal mouse anti-tubulin (clone B-5–1-2) at
1:300, and monoclonal anti-NcMIC2 (kindly provided by Dr. Gereon Schares, FLI) was used at 1:4.
Following incubations in primary antibodies, specimens were washed in PBS and were incubated
with secondary antibodies (anti-mouse Tetramethyl-rhodamine-isothiocyanate (TRITC) or anti-rabbit
Fluorescein-isothiocyanate (FITC)) both at a dilution of 1:300. For double staining, the layers were
applied sequentially, 30 min each. Following antibody staining the samples were mounted in H-1200
Vectashield mounting medium with DAPI (4′,6-diamidino-2-phenylindole; Vector Laboratories, Inc.
Burlingame, CA, USA), and viewed on a Nikon E80i fluorescence microscope. Processing of images
was performed using the Openlab 5.5.2 software (Improvision, PerkinElmer, Waltham, MA, USA).
4.5. IF-labeling of Extracellular Tachyzoites
T25 cell culture flasks, containing semi-confluent HFF monolayers were infected with 1.2 × 106
Nc-Spain7 tachyzoites and cultured for 72 h at 37 ◦C/5% CO2. Isolation of parasites was carried out
using different protocols as follows. (A) Standard 4 ◦C protocol: infected HFF monolayers were scraped
and passed through a syringe with a G25 needle at 4 ◦C to liberate the tachyzoites; (B) 21 ◦C protocol:
same procedure as in A, but all steps were undertaken at 21 ◦C and in some experiments, cultures
were treated with 5 µm BKI-1294 for 30 min, prior to scraping and during the liberation of tachyzoites;
(C) PFA-pre-fixation procedure: infected HFF monolayers were exposed shortly to 3% PFA for 5 min
prior to scraping, and braking up cells by syringe passage, all carried out at 21 ◦C in the presence of
PBS/3% PFA. Subsequent to parasite isolation, parasites, were centrifuged at 1000 × g at 21 ◦C (samples
B and C) and 4 ◦C (sample A). The pellets were carefully resuspended in 3% PFA in PBS and applied to
poly-L-lysine coated glass coverslips for 25 min at 21 ◦C, followed by centrifugation for 5 min at 1200
rpm and 21 ◦C. Tachyzoites on coverslips were processed for IF and viewed as described above.
4.6. Transmission Electron Microscopy (TEM)
To visualize the ultrastructure of MNCs, semi-confluent HFF were grown in T25 tissue culture
flasks were infected with Nc-Spain7. At 4 h post-infection the medium containing non-invaded
parasites was aspirated and fresh culture medium containing 5 µm BKI-1294 was added. Control
cultures received the corresponding amount of DMSO. Cultures were maintained at 37 ◦C/5%CO2 for
two, four, and nine days with daily supplementation of fresh medium plus/minus drug. Subsequently,
infected monolayers were washed once with 100 mm sodium cacodylate buffer (pH 7.3) and fixed in
cacodylate buffer containing 2.5% glutaraldehyde for 10 min. Monolayers were detached by careful
scraping and the suspension was centrifuged for 10 min at 1200 rpm at 21 ◦C. The supernatant was
removed and a fresh fixation solution was added. After incubation at 4 ◦C overnight, cells were
post-fixed in 2% OsO4, dehydrated in a graded series of ethanol, and embedded in Epon 820 epoxy
resin for three days with daily resin changes [11]. Specimens were polymerized at 65 ◦C overnight,
ultrathin sections were cut on a Reichert and Jung ultramicrotome (Reichert and Jung, Vienna) and
were placed on 300 mesh formvar-carbon coated nickel grids (Plano GmbH, Marburg, Germany). They
were stained in Uranyless™ and lead citrate (EMS, Hatfield, PA, USA) as described [30], and specimens
were inspected on a CM12 TEM operating at 80 kV.
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For immunogold-TEM, infected cultures at the onset of host cell lysis (partially intracellular
and extracellular tachyzoites) were fixed in 3% paraformaldehyde/0.05% glutaraldehyde for 2 h at
21 ◦C, then washed in PBS. Samples were stepwise dehydrated in ice-cold ethanol and embedded
in LR-white acrylic resin at −15 ◦C for three days with daily resin changes [29]. Sections were cut
by ultramicrotomy as above, and on-grid section labeling was performed. Following blocking of
unspecific binding sites by incubating sections in PBS/50 mm glycine/3% BSA for 1 h at 21 ◦C, the rabbit
anti-TgCDPK1 antiserum, or the corresponding rabbit pre-immune serum, was used at a dilution
of 1:250 in PBS containing 0.3% BSA for 1 h at 21 ◦C. After washing in five changes of PBS (2 min
each), goat anti-rabbit secondary antibodies conjugated to 10 nm diameter gold particles (Aurion,
Wageningen, NL) were applied at a dilution of 1:5 in PBS/0·3% BSA for 1 h. After extensive washing in
PBS, grids were air-dried and stained with Uranyless™ and lead citrate then viewed on a CM12 TEM
operating at 80 kV.
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